summary
Introduced
02/09/2023
02/09/2023
In Committee
02/16/2023
02/16/2023
Crossed Over
Passed
Dead
01/03/2025
01/03/2025
Introduced Session
118th Congress
Bill Summary
A BILL To direct the Secretary of Veterans Affairs to carry out a study and clinical trials on the effects of cannabis on certain health outcomes of veterans with chronic pain and post-traumatic stress disorder, and for other purposes.
AI Summary
This bill, the VA Medicinal Cannabis Research Act of 2023, directs the Secretary of Veterans Affairs to carry out a large-scale, mixed methods, retrospective, and qualitative study on the effects of cannabis on the health outcomes of veterans with chronic pain and post-traumatic stress disorder (PTSD). If the Secretary determines that the necessary criteria can be met, the bill also requires the Secretary to conduct a series of clinical trials evaluating the effects of cannabis on various symptoms and outcomes associated with chronic pain and PTSD in veterans. The bill includes provisions to ensure demographic representation, data preservation, and anonymity, and it clarifies that participation in the study or trials will not affect a veteran's eligibility for other VA benefits.
Committee Categories
Military Affairs and Security
Sponsors (10)
Jon Tester (D)*,
Tammy Duckworth (D),
John Fetterman (D),
John Hickenlooper (D),
Mark Kelly (D),
Angus King (I),
Jacky Rosen (D),
Kyrsten Sinema (I),
Dan Sullivan (R),
Todd Young (R),
Last Action
Motion by Senator Schumer to reconsider the vote by which cloture on the motion to proceed to S. 326 was not invoked (Record Vote No. 97) entered in Senate. (on 04/26/2023)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/118th-congress/senate-bill/326/all-info |
| BillText | https://www.congress.gov/118/bills/s326/BILLS-118s326rs.pdf |
| BillText | https://www.congress.gov/118/bills/s326/BILLS-118s326is.pdf |
Loading...